Bullous Pemphigoid Market Analysis

The bullous pemphigoid market is estimated to be valued at USD 1.4 Bn in 2024 and is expected to reach USD 2.8 Bn by 2031, growing at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031. Bullous pemphigoid is a chronic autoimmune skin disorder that predominantly affects the elderly population. Rising cases of this condition amongst this demographic segment is driving the growth of bullous pemphigoid therapeutics and treatment market globally.

The market is expected to witness a positive growth trend during the forecast period. Factors such as increasing geriatric population, rising prevalence of autoimmune skin disorders and growing healthcare expenditure across developing regions will boost the revenue of bullous pemphigoid treatment market. Also, recent drug approvals and increased research activities to develop more effective treatment options will support the market expansion through 2031. However, lack of awareness regarding this condition amongst general public may hamper the market growth potential to some extent over the coming years.